Cargando...
Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents
A growing number of studies suggest therapeutic applications of cannabidiol (CBD), a recently FDA-approved medication for epilepsy, in treatment of many other neuropsychological disorders. However, pharmacological action and the mechanisms by which CBD exerts its effects are not fully understood. He...
Guardado en:
| Publicado en: | Addict Biol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920611/ https://ncbi.nlm.nih.gov/pubmed/31215752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/adb.12783 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|